Evidence mapPaperPMID 33919145Full record

ArticleMolecules (Basel, Switzerland)2021

Antihyperglycemic and Antilipidemic Properties of a Tea Infusion of the Leaves from

Jesús Martínez-Solís, Fernando Calzada, Elizabeth Barbosa, Miguel Valdés

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Understanding the Antihyperglycemic Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Aqueous Extracts and Flavonoids Obtained fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Antihyperglycemic Effects ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  7. Experimental Approaches to Diabetes Mellitus.The Eurasian journal of medicine · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jesús Martínez-SolísInstituto Politécnico Nacional, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Plan de San Luis y Salvador Díaz Mirón S/N, Col. Casco de Santo Tomás, Miguel Hidalgo, Mexico City 11340, CP, Mexico.ORCID 0000-0003-2620-8355
Fernando CalzadaUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades 2° Piso CORSE Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Cuauhtémoc, Mexico City 06720, CP, Mexico.
Elizabeth BarbosaInstituto Politécnico Nacional, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Plan de San Luis y Salvador Díaz Mirón S/N, Col. Casco de Santo Tomás, Miguel Hidalgo, Mexico City 11340, CP, Mexico.
Miguel ValdésInstituto Politécnico Nacional, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Plan de San Luis y Salvador Díaz Mirón S/N, Col. Casco de Santo Tomás, Miguel Hidalgo, Mexico City 11340, CP, Mexico.ORCID 0000-0001-7401-303X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antihyperglycemic and antilipidemic effects of the tea infusion extracts of leaves from

Indexed as

AnimalsAnnonaBlood GlucoseBody WeightChromatography, High Pressure LiquidDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hypoglycemic AgentsHypolipidemic AgentsMiceOrgan SizePlant ExtractsPlant LeavesTeaBlood GlucoseHypoglycemic AgentsHypolipidemic AgentsPlant ExtractsTeaAnnona cherimola Millerantihyperglycemic activityantilipidemic activityHPLC analysistoxicity

Identifiers

PMID33919145
PMCPMC8122452

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.